Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy (PROSTED)
Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy: Construction and Feasibility Study
Sponsor: Centre Hospitalier Universitaire de Nīmes
A observational or N/A phase clinical study on Prostate Cancer, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire de Nīmes and has accumulated 10 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Completed
Status: Unknown → Completed
-
Oct 2024 — Feb 2026 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2022 — Jul 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Nov 2021 — Sep 2022 [monthly]
Recruiting
-
Sep 2021 — Nov 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Sep 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nīmes
For direct contact, visit the study record on ClinicalTrials.gov .